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Abstract 
A 65-year-old man with chronic hepatitis C and no history of alcohol abuse was admitted 
to our liver unit for the recent development of massive ascites and presumed 
hepatorenal syndrome. In the preceding two weeks, he had received medical treatment 
for acute pancreatitis and cholecystitis. Abdominal paracentesis demonstrated a cloudy, 
orange peritoneal fluid, with total protein concentration 3.6 g/dl, serum-ascites albumin 
gradient 1.0 g/dl, and ratios of ascites-serum bilirubin and amylase approximately 8:1. 
Diagnostic imaging demonstrated no pancreatic pseudocysts. Ten days later, at 
laparotomy, acalculous perforation of the gallbladder was identified. After 
cholecystectomy, amylase concentration in the ascitic fluid dropped within a few days to 
40% of serum values; ascites disappeared within a few weeks. We conclude that in the 
presence of a perforated gallbladder, pancreatobiliary reflux was responsible for this 
unusual combination of choleperitoneum and pancreatic ascites, which we propose to 
call pancreatobiliary ascites. 
 
Introduction 
Pancreatic ascites is a massive accumulation of peritoneal fluid with high protein 
(>3 g/dl) and amylase (>1,000 U/l) content, resulting from benign pancreatic disease [1]. 
It is an uncommon, but well recognized complication of acute and chronic pancreatitis, 
usually generated by leakage or rupture of a pancreatic pseudocyst communicating with 
the ductal system, but also the consequence of pancreatic ductal disruption after blunt  
Case Rep Gastroenterol 2008;2:433–438 
DOI: 10.1159/000161567 
Published online: November 14, 2008  © 2008 S. Karger AG, Basel 
ISSN 1662–0631 
www.karger.com/crg 
 
 
434
abdominal trauma [2]. Here we present a case of pancreatic ascites associated with 
choleperitoneum after gallbladder perforation. 
Case Report 
A 65-year-old man with chronic hepatitis C and no history of alcohol abuse was admitted to our 
liver unit for the recent development of massive ascites and presumed hepatorenal syndrome. Two 
weeks earlier he had presented to the emergency department of another hospital for sudden severe 
postprandial epigastric pain, associated with vomiting, sweating, tachycardia, and dyspnea. Serum 
amylase concentration was 4,817 U/l (reference range 0–104 U/l), total bilirubin 2.5 mg/dl (reference 
range 0.3–1.2 mg/dl) and white blood cell count 15,760 cells/mm
3. A plain abdominal film showed 
moderate distension of the stomach and a few fluid levels in the small intestine. Abdominal 
ultrasonographic examination showed gallbladder distension with pericholecystic fluid collection; no 
biliary stones were visualized. The patient was admitted to a surgery ward for acute pancreatitis with 
cholecystitis, for which a decision was made in favor of conservative treatment. In the following days, an 
abdominal CT scan showed no evidence of biliary tract dilatation, while an enlarged pancreas with mild 
Wirsung duct dilatation, massive ascites, and hepatomegaly with irregular margins were noted. Later 
during the hospital stay, a magnetic resonance cholangiopancreatography was performed, 
demonstrating a distended gallbladder with thickened walls. Despite gradual and almost complete 
normalization of serum amylase concentration, the patient’s clinical condition worsened steadily with 
progressive oliguria, and he was transferred to our unit. 
The patient was in acute distress for intense pain, fatigued and cachectic, with tense ascites. A central 
venous catheter was inserted and a paracentesis was performed. Ascitic fluid was orange-colored and 
cloudy (fig. 1), with marked leukocytosis, and bilirubin and amylase concentrations far exceeding the 
corresponding values measured on the same day in blood (table 1). The serum-ascites albumin gradient 
was 1.0 g/dl. The patient’s condition was considered too poor to sustain an endoscopic retrograde 
cholangiopancreatography, proposed in order to identify and treat a biliary fistula. Antibiotics, 
parenteral nutrition, terlipressin and albumin were started intravenously, with initial improvement of 
renal function. Cultures of ascites and blood turned positive for E. coli. On a new abdominal CT, 
pancreas morphology was reported as normal, without pseudocysts or duct dilatation. On the 11th 
hospital day, however, the patient developed frank peritonism, associated with sudden deterioration of 
liver function tests. A plain film of the abdomen showed generalized bowel distension with fluid levels 
but no evidence of free peritoneal air. Surgical exploration documented biliary peritonitis with 
gallbladder perforation; a cholecystectomy was performed, and the gallbladder was sent for pathologic 
examination (fig. 2). No biliary stones were present in the biliary tract, including the gallbladder, and 
the anatomy of the extrahepatic biliary tree was intact. Ascitic fluid amylase concentration dropped to 
normal within few days from surgery, and the patient was discharged in fair condition 30 days after his 
admission. At the last follow-up visit, 10 months later, he had fully recovered his usual body weight, 
showed no physical or ultrasonographic signs of ascites, and had platelet count and liver function tests 
within the normal reference range. 
Discussion 
To interpret this case, it is necessary to review both the clinical presentation of 
gallbladder perforation and the pathogenesis of pancreatic ascites. It is conceivable that, 
in our patient, both cholecystitis and acute pancreatitis originated from sphincter of Oddi 
dysfunction, a benign, noncalculous obstruction to the flow of bile or pancreatic juice 
through the pancreaticobiliary junction, that may be manifested clinically by 
pancreaticobiliary pain, pancreatitis, or deranged liver function tests [3]. Alternatively, 
they may have been caused by gallstone migration into the common bile duct, followed by 
spontaneous disimpact. In any case, acute pancreatitis resolved, whereas cholecystitis was 
complicated by localized gallbladder perforation, which must have been present for more 
than 10 days before surgery, since choleperitoneum with an ascitic fluid bilirubin 
concentration of approximately 33 mg/dl and an ascitic fluid/blood 8:1 ratio for bilirubin 
was documented at the diagnostic paracentesis performed on admission. Ascitic fluid  
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bilirubin concentrations above 6 mg/dl and ascitic fluid/serum bilirubin ratio greater than 
1.0 are characteristic of choleperitoneum [4]. Perforation of the gallbladder has long been 
recognized as a cause of choleperitoneum [5]; it occurs in 3–15% of patients with 
cholecystitis and is associated with significant morbidity and mortality [6]. Its clinical 
picture and diagnostic imaging are often indistinguishable from those of acute 
cholecystitis. Therefore, the diagnosis of gallbladder perforation is rarely made before 
operative exploration, as it happened in this case. 
Coming to pancreatic ascites, the driving force leading to accumulation of fluid in the 
peritoneal cavity in this rare condition (<3% of cases of ascites) is the leakage of 
protein-rich mesenteric lymph from an inflamed peritoneal surface. This peritoneal 
exudate is rich in vasoactive substances, proinflammatory mediators and activated 
lipolytic and proteolytic enzymes [7]. Typically, the ascitic fluid/serum ratio for amylase is 
6:1, with absolute values often above 1,000 U/l. In contrast, in patients with cirrhotic 
ascites the capillarization of sinusoids and the increased hydrostatic pressure due to portal 
hypertension favor the formation of ascitic fluid with low protein content and 
serum-ascites albumin gradient, i.e. the value obtained subtracting albumin in the ascitic 
fluid from albumin simultaneously measured in the serum, >1.1 g/dl. In the present case, 
the combination of a serum-ascites albumin gradient below 1.1 g/dl, a total protein level 
>3 gm/l, and elevated ascitic amylase were diagnostic of pancreatic ascites. The absence of 
a pseudocyst and the rapid and complete resolution of pancreatic ascites after 
cholecystectomy suggest that spillage of pancreatic juice into the peritoneal cavity must 
have occurred via the perforated gallbladder, necessarily in the presence of 
pancreatobiliary reflux. Indeed, when systematically searched for, evidence of occult 
pancreatobiliary reflux is found in almost all patients with acute cholecystitis, both 
calculous and acalculous [8]. Pancreatobiliary and biliopancreatic refluxes result in 
several of various pathological conditions in the biliary tract and in the pancreas, 
including acute cholecystitis and acute pancreatitis, and do not have pancreaticobiliary 
maljunction as a necessary prerequisite [9]. Therefore, these refluxes are a reasonable 
explanation for the full clinical picture of this case, although in the absence of 
secretin-stimulating magnetic resonance cholangiopancreatography imaging [10], this 
conclusion remains speculative. 
Finally, one might ask whether acalculos cholecystitis could have been favoured, in our 
patient, by the presence of liver disease (chronic hepatitis C). The literature is not 
conclusive regarding this specific issue. In a series of patients with end-stage liver disease 
and symptomatic gallbladder disease who underwent endoscopic stent insertion, 
acalcolous cholecystitis occurred in 2 out of 29 patients [11]. Diffuse lymphoplasmacytic 
acalcolous cholecystitis is a distinct form of chronic cholecystitis associated with primary 
sclerosing cholangitis [12], but not with liver disease of other etiologies. Gallbladder 
disease and fatty liver disease share similar predisposing factors, including obesity and 
insulin resistance, which play a well recognized role in hepatitis C, but these patients 
almost invariably present with gallbladder stones [13]. 
In conclusion, we propose to call pancreatobiliary ascites the combination of 
choleperitoneum with pancreatic ascites. The present case, of which we were not able to 
find other examples in the literature, reminds us of the difficulties in diagnosing 
gallbladder perforation preoperatively and of the importance of evaluating the results of 
ascitic fluid analysis with a correct, pathophysiology-oriented approach.  
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Table 1. Hematologic and biochemical laboratory data 
Hospital day  Variable Reference 
range 
On 
admission 
3   8  10  15 
White cells, per mm
3            
Blood 4,000–10,000  15,710  17,930  10,500  12,300  15,700 
Ascites N.A.  19,740  17,560  23,200  9,300  400 
Total bilirubin, mg/dl             
Serum 0.3–1.2  4.2  31  4.9  3.5  1.7 
Ascites N.A.  32.6  14.1  6.5  5.1  N.T. 
Amylase, U/l              
Serum 0–104  358  468  247  252  250 
Ascites N.A.  2,999  2,767  2,486  2,184  104 
Total protein, g/dl             
Serum 6.4–8.3  6.3  N.T.  N.T.  N.T.  N.T. 
Ascites N.A.  3.6  N.T.  2.2  2.2  2.5 
Albumin, g/dl             
Serum 3.4–4.8  2.7  N.T  2.7  1.8  3.1 
Ascites N.A.  1.7  N.T.  N.T.  N.T.  N.T. 
N.A. = Not applicable; N.T. = not tested. 
 
 
 
 
Fig. 1. Physical appearance of the ascitic fluid. 
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Fig. 2. Gross appearance of the gallbladder perforation (A) and microscopic features of mucosal 
ulceration with transmural granulation tissue and presence of bile plugs (E&E, 4×) (B). 
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